{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:23:53Z","timestamp":1787163833235,"version":"build-2736575974"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10106-7","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:51:50Z","timestamp":1764121910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NAD\u2009+\u2009in fatty liver disease: mechanistic insights and associated targets"],"prefix":"10.1007","volume":"41","author":[{"given":"Yaxin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinde","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"10106_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118540","volume":"263","author":"H Abd-Allah","year":"2020","unstructured":"Abd-Allah H, Nasr M, Ahmed-Farid OAH, Ibrahim BMM, Bakeer RM, Ahmed RF. Nicotinamide and ascorbic acid nanoparticles against the hepatic insult induced in rats by high fat high fructose diet: a comparative study. Life Sci. 2020;263:118540.","journal-title":"Life Sci"},{"issue":"8","key":"10106_CR2","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1002\/jcp.30772","volume":"237","author":"S Aggarwal","year":"2022","unstructured":"Aggarwal S, Trehanpati N, Nagarajan P, Ramakrishna G. The clock-NAD+ -sirtuin connection in nonalcoholic fatty liver disease. J Cell Physiol. 2022;237(8):3164\u201380.","journal-title":"J Cell Physiol"},{"key":"10106_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbrc.2022.12.078","volume":"643","author":"S Aggarwal","year":"2023","unstructured":"Aggarwal S, Yadav V, Maiwall R, Rastogi A, Pamecha V, Bedi O, et al. Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum. Biochem Biophys Res Commun. 2023;643:129\u201338.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10106_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125617","volume":"10","author":"TE Akie","year":"2015","unstructured":"Akie TE, Liu L, Nam M, Lei S, Cooper MP. OXPHOS-mediated induction of NAD+ promotes complete oxidation of fatty acids and interdicts non-alcoholic fatty liver disease. PLoS ONE. 2015;10(5):e0125617.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10106_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2013.10.170","volume":"442","author":"ZN Al-Abady","year":"2013","unstructured":"Al-Abady ZN, Durante B, Moody AJ, Billington RA. Large changes in NAD levels associated with CD38 expression during HL-60 cell differentiation. Biochem Biophys Res Commun. 2013;442(1\u20132):51\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10106_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/13813455.2021.1975758","volume":"130","author":"MM Allam","year":"2024","unstructured":"Allam MM, Ibrahim RM, El Gazzar WB, Said MA. Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1\/TLR4\/NF-\u03baB signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease. Arch Physiol Biochem. 2024;130(1):87\u201395.","journal-title":"Arch Physiol Biochem"},{"issue":"7","key":"10106_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","volume":"63","author":"F Ameer","year":"2014","unstructured":"Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolis. 2014;63(7):895\u2013902.","journal-title":"Metabolis"},{"issue":"6","key":"10106_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, Joukar F, Habibi A, Javid M, et al. Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries. Arch Med Res. 2024;55(6):103043.","journal-title":"Arch Med Res"},{"issue":"1","key":"10106_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40246-019-0251-1","volume":"13","author":"MA Assiri","year":"2019","unstructured":"Assiri MA, Ali HR, Marentette JO, Yun Y, Liu J, Hirschey MD, et al. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. Hum Genomics. 2019;13(1):65.","journal-title":"Hum Genomics"},{"issue":"11","key":"10106_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biology11111613","volume":"11","author":"N Attal","year":"2022","unstructured":"Attal N, Marrero E, Thompson KJ, McKillop IH. Role of AMPK-SREBP signaling in regulating fatty acid binding-4 (FABP4) expression following ethanol metabolism. Biology. 2022;11(11):1613.","journal-title":"Biology"},{"issue":"11","key":"10106_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30377","volume":"125","author":"MW Baeken","year":"2024","unstructured":"Baeken MW. Sirtuins and their influence on autophagy. J Cell Biochem. 2024;125(11):e30377.","journal-title":"J Cell Biochem"},{"issue":"13","key":"10106_CR12","doi-asserted-by":"publisher","first-page":"e00099","DOI":"10.1128\/MCB.00099-20","volume":"40","author":"L Baird","year":"2020","unstructured":"Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020;40(13):e00099-e120.","journal-title":"Mol Cell Biol"},{"issue":"53","key":"10106_CR13","doi-asserted-by":"publisher","first-page":"33260","DOI":"10.1039\/D1RA06266B","volume":"11","author":"TZ Benton","year":"2021","unstructured":"Benton TZ, Mills CM, Turner JM, Francis MJ, Solomon DJ, Burger PB, et al. Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation. RSC Adv. 2021;11(53):33260\u201370.","journal-title":"RSC Adv"},{"issue":"1","key":"10106_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12944-020-01271-1","volume":"19","author":"RK Berge","year":"2020","unstructured":"Berge RK, Cacabelos D, Se\u00f1ar\u00eds R, Nordrehaug JE, Nyg\u00e5rd O, Skorve J, et al. Hepatic steatosis induced in C57BL\/6 mice by a non-\u00df oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD+\/NADH ratio. Lipids Health Dis. 2020;19(1):94.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10106_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153019","volume":"7","author":"Y Bignon","year":"2022","unstructured":"Bignon Y, Rinaldi A, Nadour Z, Poindessous V, Nemazanyy I, Lenoir O, et al. Cell stress response impairs de novo NAD+ biosynthesis in the kidney. JCI Insight. 2022;7(1):e153019.","journal-title":"JCI Insight"},{"issue":"1","key":"10106_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1124\/jpet.116.239459","volume":"361","author":"J Boslett","year":"2017","unstructured":"Boslett J, Hemann C, Zhao YJ, Lee HC, Zweier JL. Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H). J Pharmacol Exp Ther. 2017;361(1):99\u2013108.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10106_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal B, D\u00f6lle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in parkinson\u2019s disease. Cell Metab. 2022;34(3):396-407.e6.","journal-title":"Cell Metab"},{"issue":"3","key":"10106_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/cts.12735","volume":"13","author":"F Briand","year":"2020","unstructured":"Briand F, Heymes C, Bonada L, Angles T, Charpentier J, Branchereau M, et al. A 3-week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death. Clin Transl Sci. 2020;13(3):529\u201338.","journal-title":"Clin Transl Sci"},{"issue":"6","key":"10106_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012;15(6):838\u201347.","journal-title":"Cell Metab"},{"issue":"1","key":"10106_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1186\/s12967-023-04767-3","volume":"21","author":"T Cao","year":"2023","unstructured":"Cao T, Ni R, Ding W, Ji X, Fan GC, Zhang Z, et al. Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis. J Transl Med. 2023;21(1):883.","journal-title":"J Transl Med"},{"issue":"1","key":"10106_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12916-024-03315-0","volume":"22","author":"L Cao","year":"2024","unstructured":"Cao L, An Y, Liu H, Jiang J, Liu W, Zhou Y, et al. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis. BMC Med. 2024;22(1):101.","journal-title":"BMC Med"},{"key":"10106_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fphar.2020.00548","volume":"11","author":"YT Chan","year":"2020","unstructured":"Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era? Front Pharmacol. 2020;11:548.","journal-title":"Front Pharmacol"},{"issue":"5","key":"10106_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201745124","volume":"19","author":"XF Chen","year":"2018","unstructured":"Chen XF, Tian MX, Sun RQ, Zhang ML, Zhou LS, Jin L, et al. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Rep. 2018;19(5):e45124.","journal-title":"EMBO Rep"},{"issue":"6","key":"10106_CR24","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/HEP.0000000000000314","volume":"78","author":"L Cheng","year":"2023","unstructured":"Cheng L, Deepak RNVK, Wang G, Meng Z, Tao L, Xie M, et al. Hepatic mitochondrial NAD + transporter SLC25A47 activates AMPK\u03b1 mediating lipid metabolism and tumorigenesis. Hepatology. 2023;78(6):1828\u201342.","journal-title":"Hepatology"},{"issue":"1","key":"10106_CR25","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1038\/s41598-019-46120-z","volume":"9","author":"D Conze","year":"2019","unstructured":"Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772.","journal-title":"Sci Rep"},{"issue":"2","key":"10106_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0006-8993(96)00918-3","volume":"735","author":"C Cosi","year":"1996","unstructured":"Cosi C, Chopin P, Marien M. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1\/6N mouse. Brain Res. 1996;735(2):343\u20138.","journal-title":"Brain Res"},{"issue":"2","key":"10106_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10106_CR28","doi-asserted-by":"crossref","unstructured":"Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, gut microbiota, and obesity: Links with host genetics and epigenetics and potential applications. Adv Nutr. 2019 Jan 1;10(suppl_1):S17\u201330.","DOI":"10.1093\/advances\/nmy078"},{"issue":"6","key":"10106_CR29","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1210\/jc.2009-2148","volume":"95","author":"TB Dahl","year":"2010","unstructured":"Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Dam\u00e5s JK, et al. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2010;95(6):3039\u201347.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10106_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.dld.2025.01.189","volume":"57","author":"Q Dai","year":"2025","unstructured":"Dai Q, Ain Q, Seth N, Rooney M, Zipprich A. Liver sinusoidal endothelial cells: friend or foe in metabolic dysfunction- associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis. Dig Liver Dis. 2025;57(5):493\u2013503.","journal-title":"Dig Liver Dis"},{"key":"10106_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.mce.2018.01.025","volume":"473","author":"M Dall","year":"2018","unstructured":"Dall M, Penke M, Sulek K, Matz-Soja M, Holst B, Garten A, et al. Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL\/6JBomTac mice. Mol Cell Endocrinol. 2018;473:245\u201356.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10106_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.32778","volume":"78","author":"RW Dellinger","year":"2023","unstructured":"Dellinger RW, Holmes HE, Hu-Seliger T, Butt RW, Harrison SA, Mozaffarian D, et al. Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: a double-blind, placebo-controlled clinical trial. Hepatology. 2023;78(3):863\u201377.","journal-title":"Hepatology"},{"key":"10106_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.972984","volume":"12","author":"S Deng","year":"2022","unstructured":"Deng S, Chen B, Huo J, Liu X. Therapeutic potential of NR4A1 in cancer: focus on metabolism. Front Oncol. 2022;12:972984.","journal-title":"Front Oncol"},{"issue":"4","key":"10106_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/cells12040663","volume":"12","author":"XC Dong","year":"2023","unstructured":"Dong XC. Sirtuin 6-a key regulator of hepatic lipid metabolism and liver health. Cells. 2023;12(4):663.","journal-title":"Cells"},{"issue":"2","key":"10106_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7150\/ijms.81381","volume":"20","author":"M Dong","year":"2023","unstructured":"Dong M, Wang S, Pei Z. Mechanism of CD38 via NAD+ in the development of non-alcoholic fatty liver disease. Int J Med Sci. 2023;20(2):262\u20136.","journal-title":"Int J Med Sci"},{"issue":"1","key":"10106_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1042\/BJ20090471","volume":"422","author":"AL Eggler","year":"2009","unstructured":"Eggler AL, Small E, Hannink M, Mesecar AD. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. Biochem J. 2009;422(1):171\u201380.","journal-title":"Biochem J"},{"key":"10106_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221077958","volume":"13","author":"RR El-Kady","year":"2022","unstructured":"El-Kady RR, Ali AK, El Wakeel LM, Sabri NA, Shawki MA. Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial. Ther Adv Chronic Dis. 2022;13:20406223221077958.","journal-title":"Ther Adv Chronic Dis"},{"key":"10106_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-3-031-63657-8_15","volume":"1460","author":"A Engin","year":"2024","unstructured":"Engin A. Adiponectin resistance in obesity: Adiponectin leptin\/insulin interaction. Adv Exp Med Biol. 2024;1460:431\u201362.","journal-title":"Adv Exp Med Biol"},{"key":"10106_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.970292","volume":"13","author":"C Fang","year":"2022","unstructured":"Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, et al. The AMPK pathway in fatty liver disease. Front Physiol. 2022;13:970292.","journal-title":"Front Physiol"},{"issue":"12","key":"10106_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52459","volume":"7","author":"JA Flemming","year":"2024","unstructured":"Flemming JA, Djerboua M, Chapman O, Ayonrinde O, Terrault NA. Epidemiology and outcomes of alcohol-associated hepatitis in adolescents and young adults. JAMA Netw Open. 2024;7(12):e2452459.","journal-title":"JAMA Netw Open"},{"key":"10106_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155275","volume":"135","author":"Z Fu","year":"2022","unstructured":"Fu Z, Kim H, Morse PT, Lu MJ, H\u00fcttemann M, Cambronne XA, et al. The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions. Metabolism. 2022;135:155275.","journal-title":"Metabolism"},{"issue":"1","key":"10106_CR42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.gendis.2023.02.014","volume":"11","author":"X Fu","year":"2024","unstructured":"Fu X, Li P, Zhou Q, He R, Wang G, Zhu S, et al. Mechanism of PARP inhibitor resistance and potential overcoming strategies. Genes Dis. 2024;11(1):306\u201320.","journal-title":"Genes Dis"},{"issue":"3","key":"10106_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1665-2681(19)31635-7","volume":"9","author":"R Gaddipati","year":"2010","unstructured":"Gaddipati R, Sasikala M, Padaki N, Mukherjee RM, Sekaran A, Jayaraj-Mansard M, et al. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. Ann Hepatol. 2010;9(3):266\u201370.","journal-title":"Ann Hepatol"},{"issue":"5","key":"10106_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052682","volume":"23","author":"J Gao","year":"2022","unstructured":"Gao J, Hao Y, Piao X, Gu X. Aldehyde dehydrogenase 2 as a therapeutic target in oxidative stress-related diseases: post-translational modifications deserve more attention. Int J Mol Sci. 2022;23(5):2682.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10106_CR45","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1038\/s41467-019-11078-z","volume":"10","author":"SJ Gardell","year":"2019","unstructured":"Gardell SJ, Hopf M, Khan A, Dispagna M, Hampton Sessions E, Falter R, et al. Boosting NAD+ with a small molecule that activates NAMPT. Nat Commun. 2019;10(1):3241.","journal-title":"Nat Commun"},{"issue":"4","key":"10106_CR46","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.28245","volume":"63","author":"K Gariani","year":"2016","unstructured":"Gariani K, Menzies KJ, Ryu D, Wegner CJ, Wang X, Ropelle ER, et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology. 2016;63(4):1190\u2013204.","journal-title":"Hepatology"},{"issue":"1","key":"10106_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2016.08.024","volume":"66","author":"K Gariani","year":"2017","unstructured":"Gariani K, Ryu D, Menzies KJ, Yi HS, Stein S, Zhang H, et al. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. J Hepatol. 2017;66(1):132\u201341.","journal-title":"J Hepatol"},{"issue":"2","key":"10106_CR48","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-22-0270","volume":"257","author":"B Geidl-Flueck","year":"2023","unstructured":"Geidl-Flueck B, Gerber PA. Fructose drives de novo lipogenesis affecting metabolic health. J Endocrinol. 2023;257(2):e220270.","journal-title":"J Endocrinol"},{"key":"10106_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molmet.2019.09.013","volume":"30","author":"J Giroud-Gerbetant","year":"2019","unstructured":"Giroud-Gerbetant J, Joffraud M, Giner MP, Cercillieux A, Bartova S, Makarov MV, et al. A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor. Mol Metab. 2019;30:192\u2013202.","journal-title":"Mol Metab"},{"key":"10106_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109452","volume":"122","author":"Y Gong","year":"2023","unstructured":"Gong Y, Lu Q, Xi L, Liu Y, Yang B, Su J, et al. F6P\/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish. J Nutr Biochem. 2023;122:109452.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"10106_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1021\/acsmedchemlett.3c00391","volume":"15","author":"J Gordon-Blake","year":"2024","unstructured":"Gordon-Blake J, Ratia K, Weidig V, Velma GR, Ackerman-Berrier M, Penton C, et al. Nicotinamide phosphoribosyltransferase positive allosteric modulators attenuate neuronal oxidative stress. ACS Med Chem Lett. 2024;15(2):205\u201314.","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"10106_CR52","doi-asserted-by":"publisher","first-page":"C585","DOI":"10.1152\/ajpcell.00195.2021","volume":"321","author":"A Griffiths","year":"2021","unstructured":"Griffiths A, Wang J, Song Q, Iyamu ID, Liu L, Park J, et al. Nicotinamide N-methyltransferase upregulation via the mTORC1-ATF4 pathway activation contributes to palmitate-induced lipotoxicity in hepatocytes. Am J Physiol Cell Physiol. 2021;321(3):C585\u201395.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10106_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s42255-018-0009-4","volume":"1","author":"A Grozio","year":"2019","unstructured":"Grozio A, Mills KF, Yoshino J, Bruzzone S, Sociali G, Tokizane K, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019;1(1):47\u201357.","journal-title":"Nat Metab"},{"issue":"9","key":"10106_CR54","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","volume":"55","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity. 2022;55(9):1515\u201329.","journal-title":"Immunity"},{"issue":"1","key":"10106_CR55","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1038\/s41598-025-91312-5","volume":"15","author":"Z Guo","year":"2025","unstructured":"Guo Z, Wu D, Mao R, Yao Z, Wu Q, Lv W. Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021. Sci Rep. 2025;15(1):7083.","journal-title":"Sci Rep"},{"issue":"1","key":"10106_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol: Mech Dis. 2010;5(1):253\u201395.","journal-title":"Annu Rev Pathol: Mech Dis"},{"issue":"24","key":"10106_CR57","doi-asserted-by":"publisher","first-page":"12421","DOI":"10.1039\/D1FO02577E","volume":"12","author":"L Han","year":"2021","unstructured":"Han L, Zhang Y, Li J, Xiao Y, Lu M, Li Y, et al. Phloretin attenuation of hepatic steatosis via an improvement of mitochondrial dysfunction by activating AMPK-dependent signaling pathways in C57BL\/6J mice and HepG2 cells. Food Funct. 2021;12(24):12421\u201333.","journal-title":"Food Funct"},{"key":"10106_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122209","volume":"334","author":"EHM Hassanein","year":"2023","unstructured":"Hassanein EHM, Ibrahim IM, Abd-Alhameed EK, Sharawi ZW, Jaber FA, Althagafy HS. Nrf2\/HO-1 as a therapeutic target in renal fibrosis. Life Sci. 2023;334:122209.","journal-title":"Life Sci"},{"issue":"1","key":"10106_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/13880209.2023.2292256","volume":"62","author":"S He","year":"2024","unstructured":"He S, Jiang X, Yang J, Wu Y, Shi J, Wu X, et al. Nicotinamide mononucleotide alleviates endotoxin-induced acute lung injury by modulating macrophage polarization via the SIRT1\/NF-\u03baB pathway. Pharm Biol. 2024;62(1):22\u201332.","journal-title":"Pharm Biol"},{"issue":"1","key":"10106_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40266-022-00989-0","volume":"40","author":"T Helman","year":"2023","unstructured":"Helman T, Braidy N. Importance of NAD+ anabolism in metabolic, cardiovascular and neurodegenerative disorders. Drugs Aging. 2023;40(1):33\u201348.","journal-title":"Drugs Aging"},{"issue":"2","key":"10106_CR61","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","volume":"55","author":"H Hu","year":"2020","unstructured":"Hu H, Lin A, Kong M, Yao X, Yin M, Xia H, et al. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. J Gastroenterol. 2020;55(2):142\u201358.","journal-title":"J Gastroenterol"},{"key":"10106_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.03.012","volume":"183","author":"L Hu","year":"2022","unstructured":"Hu L, Guo Y, Song L, Wen H, Sun N, Wang Y, et al. Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1\u03b1-PPAR\u03b1 pathway. Free Radic Biol Med. 2022;183:75\u201388.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"10106_CR63","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/bph.15008","volume":"178","author":"X Hua","year":"2021","unstructured":"Hua X, Sun DY, Zhang WJ, Fu JT, Tong J, Sun SJ, et al. P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21\/FGF1, via the AMP-activated protein kinase\/CREB regulated transcription coactivator 2 pathway. Br J Pharmacol. 2021;178(10):2111\u201330.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10106_CR64","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","volume":"57","author":"R Huang","year":"2015","unstructured":"Huang R, Xu Y, Wan W, Shou X, Qian J, You Z, et al. Deacetylation of nuclear LC3 drives autophagy initiation under starvation. Mol Cell. 2015;57(3):456\u201366.","journal-title":"Mol Cell"},{"issue":"5","key":"10106_CR65","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2016.11.020","volume":"66","author":"K Huang","year":"2017","unstructured":"Huang K, Du M, Tan X, Yang L, Li X, Jiang Y, et al. PARP1-mediated PPAR\u03b1 poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. J Hepatol. 2017;66(5):962\u201377.","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10106_CR66","first-page":"125","volume":"22","author":"D Ilbeigi","year":"2020","unstructured":"Ilbeigi D, Nourbakhsh M, Pasalar P, Meshkani R, Shokri Afra H, Panahi GH, et al. Nicotinamide phosphoribosyltransferase knockdown leads to lipid accumulation in HepG2 cells through the SIRT1-AMPK pathway. Cell J. 2020;22(Suppl 1):125\u201332.","journal-title":"Cell J"},{"issue":"7","key":"10106_CR67","volume":"7","author":"F Ilyas","year":"2023","unstructured":"Ilyas F, Ali H, Patel P, Basuli D, Giammarino A, Satapathy SK. Rising alcohol-associated liver disease-related mortality rates in the united states from 1999 to 2022. Hepatol Commun. 2023;7(7):e00180.","journal-title":"Hepatol Commun"},{"issue":"18","key":"10106_CR68","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"44","key":"10106_CR69","doi-asserted-by":"publisher","first-page":"15597","DOI":"10.1073\/pnas.0405238101","volume":"101","author":"S Ishii","year":"2004","unstructured":"Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci U S A. 2004;101(44):15597\u2013602.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10106_CR70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11154-019-09510-2","volume":"20","author":"SM Ishtiaq","year":"2019","unstructured":"Ishtiaq SM, Rashid H, Hussain Z, Arshad MI, Khan JA. Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease. Rev Endocr Metab Disord. 2019;20(3):253\u201361.","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"10106_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado JdeD, Popovich PG, Partida-Sanchez S, et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE. 2015;10(12):e0145342.","journal-title":"PLoS ONE"},{"key":"10106_CR72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2019.03.064","volume":"225","author":"R Jiang","year":"2019","unstructured":"Jiang R, Zhou Y, Wang S, Pang N, Huang Y, Ye M, et al. Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of smads signaling pathway. Life Sci. 2019;225:20\u20138.","journal-title":"Life Sci"},{"issue":"1","key":"10106_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","volume":"119","author":"LL Jophlin","year":"2024","unstructured":"Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, et al. ACG clinical guideline: Alcohol-associated liver disease. Am J Gastroenterol. 2024;119(1):30\u201354.","journal-title":"Am J Gastroenterol"},{"key":"10106_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100858","volume":"79","author":"K Kaarniranta","year":"2020","unstructured":"Kaarniranta K, Uusitalo H, Blasiak J, Felszeghy S, Kannan R, Kauppinen A, et al. Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res. 2020;79:100858.","journal-title":"Prog Retin Eye Res"},{"key":"10106_CR75","doi-asserted-by":"crossref","unstructured":"Kang R, Tang D. Nuclear DAMPs in hepatic injury and inflammation. In: Ding WX, Yin XM, editors. Molecules, systems and signaling in liver injury. Cham: Springer International Publishing; 2017. p. 133\u201358.","DOI":"10.1007\/978-3-319-58106-4_7"},{"issue":"1","key":"10106_CR76","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/s41598-018-22081-7","volume":"8","author":"A Kannt","year":"2018","unstructured":"Kannt A, Rajagopal S, Kadnur SV, Suresh J, Bhamidipati RK, Swaminathan S, et al. A small molecule inhibitor of nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep. 2018;8(1):3660.","journal-title":"Sci Rep"},{"issue":"5","key":"10106_CR77","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","volume":"79","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME. Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease. Hepatology. 2024;79(5):1212\u20139.","journal-title":"Hepatology"},{"issue":"9","key":"10106_CR78","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.2174\/0929867331666230815113921","volume":"32","author":"M Khoshakhlagh","year":"2025","unstructured":"Khoshakhlagh M, Butler AE, Jamialahmadi T, Sahebkar A. Protective effects of curcumin against alcoholic fatty liver. Curr Med Chem. 2025;32(9):1702\u201317.","journal-title":"Curr Med Chem"},{"key":"10106_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102920","volume":"68","author":"LO Klotz","year":"2023","unstructured":"Klotz LO, Carlberg C. Nutrigenomics and redox regulation: concepts relating to the special issue on nutrigenomics. Redox Biol. 2023;68:102920.","journal-title":"Redox Biol"},{"key":"10106_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1182037","volume":"14","author":"T Kongmalai","year":"2023","unstructured":"Kongmalai T, Srinonprasert V, Anothaisintawee T, Kongmalai P, McKay G, Attia J, et al. New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023;14:1182037.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7495","key":"10106_CR81","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","volume":"508","author":"D Kraus","year":"2014","unstructured":"Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258\u201362.","journal-title":"Nature"},{"issue":"6","key":"10106_CR82","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11095-010-0096-8","volume":"27","author":"JK Kundu","year":"2010","unstructured":"Kundu JK, Surh YJ. Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharm Res. 2010;27(6):999\u20131013.","journal-title":"Pharm Res"},{"issue":"13","key":"10106_CR83","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1021\/acs.jmedchem.2c00688","volume":"65","author":"B Lagu","year":"2022","unstructured":"Lagu B, Wu X, Kulkarni S, Paul R, Becherer JD, Olson L, et al. Orally bioavailable enzymatic inhibitor of CD38, MK-0159, protects against ischemia\/reperfusion injury in the murine heart. J Med Chem. 2022;65(13):9418\u201346.","journal-title":"J Med Chem"},{"issue":"Suppl 4","key":"10106_CR84","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/ijo.2008.123","volume":"32","author":"MD Lane","year":"2008","unstructured":"Lane MD, Wolfgang M, Cha SH, Dai Y. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA. Int J Obes (Lond). 2008;32(Suppl 4):S49-54.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10106_CR85","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10106_CR86","doi-asserted-by":"crossref","unstructured":"Le P, Tatar M, Dasarathy S, Alkhouri N, Herman WH, Taksler GB, et al. Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050. JAMA Netw Open. 2025;8(1):e2454707.","DOI":"10.1001\/jamanetworkopen.2024.54707"},{"issue":"9","key":"10106_CR87","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1073\/pnas.0712145105","volume":"105","author":"IH Lee","year":"2008","unstructured":"Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A. 2008;105(9):3374\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10106_CR88","doi-asserted-by":"publisher","first-page":"496","DOI":"10.14348\/molcells.2023.0045","volume":"46","author":"SJ Lee","year":"2023","unstructured":"Lee SJ, Choi SE, Park S, Hwang Y, Son Y, Kang Y. CD38 inhibition protects fructose-induced toxicity in primary hepatocytes. Mol Cells. 2023;46(8):496\u2013512.","journal-title":"Mol Cells"},{"issue":"1","key":"10106_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01108-8","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Qi J, Tang Y, Liu H, Zhou K, Dai Z, et al. A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p\/miR-320a and ABCA1\/CPT1 axis. J Nanobiotechnology. 2021;19(1):363.","journal-title":"J Nanobiotechnology"},{"issue":"5","key":"10106_CR90","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1142\/S0192415X21500592","volume":"49","author":"BS Li","year":"2021","unstructured":"Li BS, Zhu RZ, Lim SH, Seo JH, Choi BM. Apigenin alleviates oxidative stress-induced cellular senescence via modulation of the SIRT1-NAD[formula: see text]-CD38 axis. Am J Chin Med. 2021;49(5):1235\u201350.","journal-title":"Am J Chin Med"},{"key":"10106_CR91","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67381","volume":"10","author":"WH Li","year":"2021","unstructured":"Li WH, Huang K, Cai Y, Wang QW, Zhu WJ, Hou YN, et al. Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate. Elife. 2021;10:e67381.","journal-title":"Elife"},{"issue":"9","key":"10106_CR92","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.7150\/thno.53652","volume":"11","author":"DJ Li","year":"2021","unstructured":"Li DJ, Sun SJ, Fu JT, Ouyang SX, Zhao QJ, Su L, et al. NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5\/irisin. Theranostics. 2021;11(9):4381\u2013402.","journal-title":"Theranostics"},{"key":"10106_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.775649","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Li Y, Jin X, Liao Q, Chen Z, Peng H, et al. CD38: a significant regulator of macrophage function. Front Oncol. 2022;12:775649.","journal-title":"Front Oncol"},{"issue":"18","key":"10106_CR94","doi-asserted-by":"publisher","first-page":"12762","DOI":"10.1021\/acs.jmedchem.3c00391","volume":"66","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Zhang Y, Wu Y, Xing Z, Wang J, et al. Discovery of a first-in-class CD38 inhibitor for the treatment of mitochondrial myopathy. J Med Chem. 2023;66(18):12762\u201375.","journal-title":"J Med Chem"},{"issue":"12","key":"10106_CR95","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3390\/biomedicines11123280","volume":"11","author":"N Li","year":"2023","unstructured":"Li N, Li X, Ding Y, Liu X, Diggle K, Kisseleva T, et al. SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies. Biomedicines. 2023;11(12):3280.","journal-title":"Biomedicines"},{"key":"10106_CR96","doi-asserted-by":"crossref","unstructured":"Li et al Li J, Dou X, Li S, Zhang X, Zeng Y, Song Z. Nicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP\/PKA\/CREB pathway-dependent Sirt1 upregulation. Biochim Biophys Acta. 2015;1853(11 Pt A):2929\u201336.","DOI":"10.1016\/j.bbamcr.2015.09.003"},{"issue":"5","key":"10106_CR97","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.gendis.2022.03.019","volume":"10","author":"G Liang","year":"2023","unstructured":"Liang G, Li Y, Lin Y, Yang X, Yang J, Hu S, et al. Nicotinamide N-methyltransferase and liver diseases. Genes Dis. 2023;10(5):1883\u201393.","journal-title":"Genes Dis"},{"key":"10106_CR98","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757\u201372.","journal-title":"Clin Interv Aging"},{"issue":"6","key":"10106_CR99","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1073\/pnas.0630588100","volume":"100","author":"LL Listenberger","year":"2003","unstructured":"Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA. 2003;100(6):3077\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10106_CR100","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jep.2013.10.020","volume":"150","author":"L Liu","year":"2013","unstructured":"Liu L, Yang M, Lin X, Li Y, Liu C, Yang Y, et al. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J Ethnopharmacol. 2013;150(3):1045\u201352.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"10106_CR101","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1002\/fsn3.4159","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cheng C, Gao H, Zhu XJ, He X, Zhou MX, et al. Restoring energy metabolism by NAD+ supplement prevents alcohol-induced liver injury and boosts liver regeneration. Food Sci Nutr. 2024;12(7):5100\u201310.","journal-title":"Food Sci Nutr"},{"issue":"5","key":"10106_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052707","volume":"23","author":"R Lombardi","year":"2022","unstructured":"Lombardi R, Piciotti R, Dongiovanni P, Meroni M, Fargion S, Fracanzani AL. PD-1\/PD-L1 immuno-mediated therapy in NAFLD: advantages and obstacles in the treatment of advanced disease. Int J Mol Sci. 2022;23(5):2707.","journal-title":"Int J Mol Sci"},{"key":"10106_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.112019","volume":"110","author":"L Longo","year":"2023","unstructured":"Longo L, de Castro JM, Keingeski MB, Rampelotto PH, Stein DJ, Guerreiro GTS, et al. Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet-induced obesity in rats. Nutrition. 2023;110:112019.","journal-title":"Nutrition"},{"issue":"10","key":"10106_CR104","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"1","key":"10106_CR105","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11033-019-05136-4","volume":"47","author":"SS Loza-Medrano","year":"2020","unstructured":"Loza-Medrano SS, Baiza-Gutman LA, Manuel-Apolinar L, Garc\u00eda-Macedo R, Damasio-Santana L, Mart\u00ednez-Mar OA, et al. High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes. Mol Biol Rep. 2020;47(1):337\u201351.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"10106_CR106","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1021\/acs.jproteome.2c00167","volume":"21","author":"C Luo","year":"2022","unstructured":"Luo C, Ding W, Yang C, Zhang W, Liu X, Deng H. Nicotinamide mononucleotide administration restores redox homeostasis via the Sirt3-Nrf2 axis and protects aged mice from oxidative stress-induced liver injury. J Proteome Res. 2022;21(7):1759\u201370.","journal-title":"J Proteome Res"},{"issue":"3","key":"10106_CR107","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155(3):629\u201347.","journal-title":"Gastroenterology"},{"issue":"1","key":"10106_CR108","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.","journal-title":"Nat Commun"},{"key":"10106_CR109","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ejphar.2017.10.048","volume":"818","author":"S\u00c1 Mej\u00eda","year":"2018","unstructured":"Mej\u00eda S\u00c1, Gutman LAB, Camarillo CO, Navarro RM, Becerra MCS, Santana LD, et al. Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH\/NADP+ and GSH\/GSSG ratios and reducing oxidative and inflammatory stress. Eur J Pharmacol. 2018;818:499\u2013507.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10106_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100111","volume":"65","author":"KA M\u00e9ndez-Lara","year":"2021","unstructured":"M\u00e9ndez-Lara KA, Rodr\u00edguez-Mill\u00e1n E, Sebasti\u00e1n D, Blanco-Soto R, Camacho M, Nan MN, et al. Nicotinamide protects against diet-induced body weight gain, increases energy expenditure, and induces white adipose tissue beiging. Mol Nutr Food Res. 2021;65(11):e2100111.","journal-title":"Mol Nutr Food Res"},{"key":"10106_CR111","doi-asserted-by":"crossref","unstructured":"Ming G feng, Li X, Yin J ye, Ai Y hang, Xu D miao, Ma X hua, et al. JAZF1 regulates visfatin expression in adipocytes via PPAR\u03b1 and PPAR\u03b2\/\u03b4 signaling. Metabolism. 2014;63(8):1012\u201321.","DOI":"10.1016\/j.metabol.2014.05.006"},{"issue":"3","key":"10106_CR112","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmet.2018.02.001","volume":"27","author":"SJ Mitchell","year":"2018","unstructured":"Mitchell SJ, Bernier M, Aon MA, Cortassa S, Kim EY, Fang EF, et al. Nicotinamide improves aspects of healthspan, but not lifespan, in mice. Cell Metab. 2018;27(3):667-676.e4.","journal-title":"Cell Metab"},{"issue":"1","key":"10106_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1556\/2060.2023.00128","volume":"110","author":"MS Mohan","year":"2023","unstructured":"Mohan MS, Sreedevi AS, Sakunthala AN, Boban PT, Sudhakaran PR, Kamalamma S. Intermittent cold exposure upregulates regulators of cardiac mitochondrial biogenesis and function in mice. Physiol Int. 2023;110(1):1\u201318.","journal-title":"Physiol Int"},{"key":"10106_CR114","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbrc.2023.149167","volume":"687","author":"NT Moldogazieva","year":"2023","unstructured":"Moldogazieva NT, Zavadskiy SP, Astakhov DV, Terentiev AA. Lipid peroxidation: Reactive carbonyl species, protein\/DNA adducts, and signaling switches in oxidative stress and cancer. Biochem Biophys Res Commun. 2023;687:149\u201367.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10106_CR115","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","volume":"66","author":"P Mukhopadhyay","year":"2017","unstructured":"Mukhopadhyay P, Horv\u00e1th B, Rajesh M, Varga ZV, Gariani K, Ryu D, et al. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J Hepatol. 2017;66(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"6","key":"10106_CR116","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/nu15061494","volume":"15","author":"T Nagahisa","year":"2023","unstructured":"Nagahisa T, Kosugi S, Yamaguchi S. Interactions between intestinal homeostasis and NAD+ biology in regulating incretin production and postprandial glucose metabolism. Nutrients. 2023;15(6):1494.","journal-title":"Nutrients"},{"key":"10106_CR117","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bcp.2019.02.008","volume":"163","author":"H Neelakantan","year":"2019","unstructured":"Neelakantan H, Brightwell CR, Graber TG, Maroto R, Wang HYL, McHardy SF, et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem Pharmacol. 2019;163:481\u201392.","journal-title":"Biochem Pharmacol"},{"key":"10106_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108639","volume":"257","author":"Y Ning","year":"2024","unstructured":"Ning Y, Dou X, Wang Z, Shi K, Wang Z, Ding C, et al. SIRT3: a potential therapeutic target for liver fibrosis. Pharmacol Ther. 2024;257:108639.","journal-title":"Pharmacol Ther"},{"key":"10106_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110931","volume":"112","author":"J Noone","year":"2023","unstructured":"Noone J, Rochfort KD, O\u2019Sullivan F, O\u2019Gorman DJ. SIRT4 is a regulator of human skeletal muscle fatty acid metabolism influencing inner and outer mitochondrial membrane-mediated fusion. Cell Signal. 2023;112:110931.","journal-title":"Cell Signal"},{"key":"10106_CR120","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.imlet.2018.06.007","volume":"205","author":"E Ortolan","year":"2019","unstructured":"Ortolan E, Augeri S, Fissolo G, Musso I, Funaro A. CD157: from immunoregulatory protein to potential therapeutic target. Immunol Lett. 2019;205:59\u201364.","journal-title":"Immunol Lett"},{"issue":"3","key":"10106_CR121","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbrc.2018.02.115","volume":"498","author":"ZG Pan","year":"2018","unstructured":"Pan ZG, An XS. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. Biochem Biophys Res Commun. 2018;498(3):416\u201323.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10106_CR122","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.14857","volume":"8","author":"CW Pan","year":"2025","unstructured":"Pan CW, Abboud Y, Chitnis A, Zhang W, Singal AK, Wong RJ. Alcohol-associated liver disease mortality. JAMA Netw Open. 2025;8(6):e2514857.","journal-title":"JAMA Netw Open"},{"issue":"29","key":"10106_CR123","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1080\/10408398.2022.2070722","volume":"63","author":"S Pande","year":"2023","unstructured":"Pande S, Raisuddin S. Molecular and cellular regulatory roles of sirtuin protein. Crit Rev Food Sci Nutr. 2023;63(29):9895\u2013913.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10106_CR124","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jcb.22919","volume":"112","author":"J Pang","year":"2011","unstructured":"Pang J, Gong H, Xi C, Fan W, Dai Y, Zhang TM. Poly(ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes. J Cell Biochem. 2011;112(1):299\u2013306.","journal-title":"J Cell Biochem"},{"key":"10106_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110836","volume":"132","author":"KH Park","year":"2020","unstructured":"Park KH, Kim SH. Adult zebrafish as an in vivo drug testing model for ethanol induced acute hepatic injury. Biomed Pharmacother. 2020;132:110836.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10106_CR126","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep4.1530","volume":"4","author":"R Parker","year":"2020","unstructured":"Parker R, Schmidt MS, Cain O, Gunson B, Brenner C. Nicotinamide adenine dinucleotide metabolome is functionally depressed in patients undergoing liver transplantation for alcohol-related liver disease. Hepatol Commun. 2020;4(8):1183\u201392.","journal-title":"Hepatol Commun"},{"issue":"5","key":"10106_CR127","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/hep.27297","volume":"60","author":"M Pawlak","year":"2014","unstructured":"Pawlak M, Baug\u00e9 E, Bourguet W, De Bosscher K, Lalloyer F, Tailleux A, et al. The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. Hepatology. 2014;60(5):1593\u2013606.","journal-title":"Hepatology"},{"issue":"8","key":"10106_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081854","volume":"13","author":"S Pezzino","year":"2025","unstructured":"Pezzino S, Puleo S, Luca T, Castorina M, Castorina S. Adipokine and hepatokines in metabolic dysfunction-associated steatotic liver disease (MASLD): current and developing trends. Biomedicines. 2025;13(8):1854.","journal-title":"Biomedicines"},{"issue":"9","key":"10106_CR129","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.bbadis.2019.06.009","volume":"1865","author":"TX Pham","year":"2019","unstructured":"Pham TX, Bae M, Kim MB, Lee Y, Hu S, Kang H, et al. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis. Biochimica Et Biophysica Acta (BBA). 2019;1865(9):2451\u201363.","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"issue":"9","key":"10106_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091637","volume":"11","author":"B Polj\u0161ak","year":"2022","unstructured":"Polj\u0161ak B, Kova\u010d V, Milisav I. Current uncertainties and future challenges regarding NAD+ boosting strategies. Antioxidants. 2022;11(9):1637.","journal-title":"Antioxidants"},{"issue":"1","key":"10106_CR131","volume":"1874","author":"L Ponnusamy","year":"2020","unstructured":"Ponnusamy L, Natarajan SR, Thangaraj K, Manoharan R. Therapeutic aspects of AMPK in breast cancer: progress, challenges, and future directions. Biochimica Et Biophysica Acta (BBA). 2020;1874(1):188379.","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"key":"10106_CR132","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/jcag\/gwae057","volume":"2","author":"KJ Potter","year":"2025","unstructured":"Potter KJ, Phinney J, Kulai T, Munro V. Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Can Assoc Gastroenterol. 2025;2:47\u201357.","journal-title":"J Can Assoc Gastroenterol"},{"issue":"10290","key":"10106_CR133","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"10106_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112659","volume":"147","author":"Q Pu","year":"2022","unstructured":"Pu Q, Guo XX, Hu JJ, Li AL, Li GG, Li XY. Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1\/Nrf2\/HO-1 pathway. Biomed Pharmacother. 2022;147:112659.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10106_CR135","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.3390\/nu13103532","volume":"13","author":"S Quesada-V\u00e1zquez","year":"2021","unstructured":"Quesada-V\u00e1zquez S, Colom-Pellicer M, Navarro-Masip \u00c8, Aragon\u00e8s G, Del Bas JM, Caimari A, et al. Supplementation with a specific combination of metabolic cofactors ameliorates non-alcoholic fatty liver disease, hepatic fibrosis, and insulin resistance in mice. Nutrients. 2021;13(10):3532.","journal-title":"Nutrients"},{"key":"10106_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115861","volume":"217","author":"E Ramos-Tovar","year":"2023","unstructured":"Ramos-Tovar E, Muriel P. Nlrp3 inflammasome in hepatic diseases: a pharmacological target. Biochem Pharmacol. 2023;217:115861.","journal-title":"Biochem Pharmacol"},{"key":"10106_CR137","doi-asserted-by":"publisher","first-page":"13103","DOI":"10.1038\/ncomms13103","volume":"7","author":"J Ratajczak","year":"2016","unstructured":"Ratajczak J, Joffraud M, Trammell SAJ, Ras R, Canela N, Boutant M, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun. 2016;7:13103.","journal-title":"Nat Commun"},{"issue":"6","key":"10106_CR138","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41574-023-00809-4","volume":"19","author":"M R\u00e9gnier","year":"2023","unstructured":"R\u00e9gnier M, Carbinatti T, Parlati L, Benhamed F, Postic C. The role of ChREBP in carbohydrate sensing and NAFLD development. Nat Rev Endocrinol. 2023;19(6):336\u201349.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10106_CR139","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ajcn\/nqaa072","volume":"112","author":"CME Remie","year":"2020","unstructured":"Remie CME, Roumans KHM, Moonen MPB, Connell NJ, Havekes B, Mevenkamp J, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am J Clin Nutr. 2020;112(2):413\u201326.","journal-title":"Am J Clin Nutr"},{"key":"10106_CR140","doi-asserted-by":"crossref","unstructured":"Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol. 2013;28 Suppl 1(0 1):38\u201342.","DOI":"10.1111\/jgh.12019"},{"issue":"2","key":"10106_CR141","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/tox.23021","volume":"36","author":"GR Romualdo","year":"2021","unstructured":"Romualdo GR, Da Silva TC, de Albuquerque Landi MF, Morais J\u00c1, Barbisan LF, Vinken M, et al. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease. Environ Toxicol. 2021;36(2):168\u201376.","journal-title":"Environ Toxicol"},{"issue":"1","key":"10106_CR142","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/s41598-022-19634-2","volume":"12","author":"S Ruf","year":"2022","unstructured":"Ruf S, Rajagopal S, Kadnur SV, Hallur MS, Rani S, Kristam R, et al. Novel tricyclic small molecule inhibitors of nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep. 2022;12(1):15440.","journal-title":"Sci Rep"},{"issue":"12","key":"10106_CR143","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgh.14740","volume":"34","author":"WK Saeed","year":"2019","unstructured":"Saeed WK, Jun DW, Jang K, Oh JH, Chae YJ, Lee JS, et al. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase. J of Gastro and Hepatol. 2019;34(12):2206\u201318.","journal-title":"J of Gastro and Hepatol"},{"issue":"18","key":"10106_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184359","volume":"20","author":"K Salic","year":"2019","unstructured":"Salic K, Gart E, Seidel F, Verschuren L, Caspers M, van Duyvenvoorde W, et al. Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis. Int J Mol Sci. 2019;20(18):4359.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10106_CR145","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/pathogens12070964","volume":"12","author":"DV Santinelli-Pestana","year":"2023","unstructured":"Santinelli-Pestana DV, Aikawa E, Singh SA, Aikawa M. PARPs and ADP-ribosylation in chronic inflammation: a focus on macrophages. Pathogens. 2023;12(7):964.","journal-title":"Pathogens"},{"issue":"16\u201318","key":"10106_CR146","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/ars.2023.0295","volume":"39","author":"L Santos","year":"2023","unstructured":"Santos L, Benitez-Rosendo A, Bresque M, Camacho-Pereira J, Calliari A, Escande C. Sirtuins: the NAD+-dependent multifaceted modulators of inflammation. Antioxid Redox Signal. 2023;39(16\u201318):1185\u2013208.","journal-title":"Antioxid Redox Signal"},{"key":"10106_CR147","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3389\/fphys.2018.01648","volume":"9","author":"M S\u00e1rk\u00f6zy","year":"2018","unstructured":"S\u00e1rk\u00f6zy M, Kov\u00e1cs ZZA, Kov\u00e1cs MG, G\u00e1sp\u00e1r R, Sz\u0171cs G, Dux L. Mechanisms and modulation of oxidative\/nitrative stress in type 4 cardio-renal syndrome and renal sarcopenia. Front Physiol. 2018;9:1648.","journal-title":"Front Physiol"},{"issue":"1","key":"10106_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2017.03.026","volume":"19","author":"A Sathyanarayan","year":"2017","unstructured":"Sathyanarayan A, Mashek MT, Mashek DG. ATGL promotes autophagy\/lipophagy via SIRT1 to control hepatic lipid droplet catabolism. Cell Rep. 2017;19(1):1\u20139.","journal-title":"Cell Rep"},{"key":"10106_CR149","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.biochem.74.082803.133500","volume":"75","author":"AA Sauve","year":"2006","unstructured":"Sauve AA, Wolberger C, Schramm VL, Boeke JD. The biochemistry of sirtuins. Annu Rev Biochem. 2006;75:435\u201365.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10106_CR150","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"6","author":"E Scorletti","year":"2022","unstructured":"Scorletti E, Carr RM. A new perspective on NAFLD: focusing on lipid droplets. J Hepatol. 2022;6(4):934\u201345.","journal-title":"J Hepatol"},{"issue":"1","key":"10106_CR151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4(1):16.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10106_CR152","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1111\/ejn.16167","volume":"58","author":"AH Shehata","year":"2023","unstructured":"Shehata AH, Anter AF, Ahmed ASF. Role of SIRT1 in sepsis-induced encephalopathy: molecular targets for future therapies. Eur J Neurosci. 2023;58(10):4211\u201335.","journal-title":"Eur J Neurosci"},{"key":"10106_CR153","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nutres.2017.03.005","volume":"40","author":"C Shen","year":"2017","unstructured":"Shen C, Dou X, Ma Y, Ma W, Li S, Song Z. Nicotinamide protects hepatocytes against palmitate-induced lipotoxicity via SIRT1-dependent autophagy induction. Nutr Res. 2017;40:40\u20137.","journal-title":"Nutr Res"},{"issue":"8","key":"10106_CR154","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600878","volume":"61","author":"W Shi","year":"2017","unstructured":"Shi W, Hegeman MA, van Dartel DAM, Tang J, Suarez M, Swarts H, et al. Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. Mol Nutr Food Res. 2017;61(8):1600878.","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"10106_CR155","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","volume":"82","author":"Y Shi","year":"2022","unstructured":"Shi Y, Kerry PS, Nanson JD, Bosanac T, Sasaki Y, Krauss R, et al. Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules. Mol Cell. 2022;82(9):1643-1659.e10.","journal-title":"Mol Cell"},{"issue":"4","key":"10106_CR156","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7570\/jomes23054","volume":"32","author":"S Shin","year":"2023","unstructured":"Shin S, Kim J, Lee JY, Kim J, Oh CM. Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD). J Obes Metab Syndr. 2023;32(4):289\u2013302.","journal-title":"J Obes Metab Syndr"},{"issue":"5","key":"10106_CR157","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10565-019-09463-x","volume":"35","author":"WC Sim","year":"2019","unstructured":"Sim WC, Kim DG, Lee W, Sim H, Choi YJ, Lee BH. Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes. Cell Biol Toxicol. 2019;35(5):457\u201370.","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"10106_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/genes14030553","volume":"14","author":"RA Sinha","year":"2023","unstructured":"Sinha RA. Autophagy: a cellular guardian against hepatic lipotoxicity. Genes. 2023;14(3):553.","journal-title":"Genes"},{"issue":"1","key":"10106_CR159","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1038\/s41467-021-25457-y","volume":"12","author":"AC Sletten","year":"2021","unstructured":"Sletten AC, Davidson JW, Yagabasan B, Moores S, Schwaiger-Haber M, Fujiwara H, et al. Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis. Nat Commun. 2021;12(1):5214.","journal-title":"Nat Commun"},{"issue":"3","key":"10106_CR160","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest. 2020;130(3):1453\u201360.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10106_CR161","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","volume":"325","author":"S Song","year":"2010","unstructured":"Song S, Attia RR, Connaughton S, Niesen MI, Ness GC, Elam MB, et al. Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements. Mol Cell Endocrinol. 2010;325(1\u20132):54\u201363.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10106_CR162","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.04.038","volume":"73","author":"Q Song","year":"2020","unstructured":"Song Q, Chen Y, Wang J, Hao L, Huang C, Griffiths A, et al. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J Hepatol. 2020;73(4):783\u201393.","journal-title":"J Hepatol"},{"key":"10106_CR163","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3389\/fimmu.2018.02795","volume":"9","author":"EC Stahl","year":"2018","unstructured":"Stahl EC, Haschak MJ, Popovic B, Brown BN. Macrophages in the aging liver and age-related liver disease. Front Immunol. 2018;9:2795.","journal-title":"Front Immunol"},{"issue":"4","key":"10106_CR164","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1002\/jcb.26649","volume":"120","author":"S Sun","year":"2019","unstructured":"Sun S, Hu Y, Zheng Q, Guo Z, Sun D, Chen S, et al. Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity. J Cell Biochem. 2019;120(4):4813\u201326.","journal-title":"J Cell Biochem"},{"key":"10106_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.125242","volume":"267","author":"Y Sun","year":"2024","unstructured":"Sun Y, Wu Q, Fu Q, Cong H, Shen Y, Yu B, et al. Reactive oxygen species-responsive polyprodrug micelles deliver cell cycle regulators for chemosensitization. Talanta. 2024;267:125242.","journal-title":"Talanta"},{"issue":"1","key":"10106_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-024-03889-x","volume":"99","author":"G Svobodov\u00e1","year":"2025","unstructured":"Svobodov\u00e1 G, Horn\u00ed M, Veleck\u00e1 E, Bou\u0161ov\u00e1 I. Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review. Arch Toxicol. 2025;99(1):1\u201322.","journal-title":"Arch Toxicol"},{"issue":"1\u20134","key":"10106_CR167","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2018.11.008","volume":"507","author":"K Takeuchi","year":"2018","unstructured":"Takeuchi K, Yokouchi C, Goto H, Umehara K, Yamada H, Ishii Y. Alleviation of fatty liver in a rat model by enhancing N1-methylnicotinamide bioavailability through aldehyde oxidase inhibition. Biochem Biophys Res Commun. 2018;507(1\u20134):203\u201310.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10106_CR168","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1002\/ptr.7033","volume":"35","author":"M Talebi","year":"2021","unstructured":"Talebi M, Talebi M, Farkhondeh T, Mishra G, \u0130lg\u00fcn S, Samarghandian S. New insights into the role of the Nrf2 signaling pathway in green tea catechin applications. Phytother Res. 2021;35(6):3078\u2013112.","journal-title":"Phytother Res"},{"issue":"2","key":"10106_CR169","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL. Sirt1 and the mitochondria. Mol Cells. 2016;39(2):87\u201395.","journal-title":"Mol Cells"},{"key":"10106_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1469830","volume":"15","author":"Y Tang","year":"2024","unstructured":"Tang Y, Ju W, Liu Y, Deng Q. The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy. Front Pharmacol. 2024;15:1469830.","journal-title":"Front Pharmacol"},{"key":"10106_CR171","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S2468-1253(22)00338-7","volume":"2","author":"G Targher","year":"2023","unstructured":"Targher G, Mantovani A, Byrne CD. Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2023;2:179\u201391.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10106_CR172","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cmet.2018.03.016","volume":"27","author":"MG Tarrag\u00f3","year":"2018","unstructured":"Tarrag\u00f3 MG, Chini CCS, Kanamori KS, Warner GM, Caride A, de Oliveira GC, et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab. 2018;27(5):1081-1095.e10.","journal-title":"Cell Metab"},{"key":"10106_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107155","volume":"203","author":"C Tian","year":"2024","unstructured":"Tian C, Huang R, Xiang M. SIRT1: harnessing multiple pathways to hinder NAFLD. Pharmacol Res. 2024;203:107155.","journal-title":"Pharmacol Res"},{"key":"10106_CR174","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SAJ Trammell","year":"2016","unstructured":"Trammell SAJ, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948.","journal-title":"Nat Commun"},{"issue":"3","key":"10106_CR175","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","volume":"53","author":"S Tran","year":"2020","unstructured":"Tran S, Baba I, Poupel L, Dussaud S, Moreau M, G\u00e9lineau A, et al. Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity. 2020;53(3):627-640.e5.","journal-title":"Immunity"},{"issue":"1","key":"10106_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14866-z","volume":"7","author":"GM Uddin","year":"2017","unstructured":"Uddin GM, Youngson NA, Doyle BM, Sinclair DA, Morris MJ. Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise. Sci Rep. 2017;7(1):15063.","journal-title":"Sci Rep"},{"issue":"4","key":"10106_CR177","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/cells9040791","volume":"9","author":"GM Uddin","year":"2020","unstructured":"Uddin GM, Youngson NA, Chowdhury SS, Hagan C, Sinclair DA, Morris MJ. Administration of nicotinamide mononucleotide (NMN) reduces metabolic impairment in male mouse offspring from obese mothers. Cells. 2020;9(4):791.","journal-title":"Cells"},{"issue":"3","key":"10106_CR178","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.stem.2018.01.010","volume":"22","author":"T Wakabayashi","year":"2018","unstructured":"Wakabayashi T, Naito H, Suehiro JI, Lin Y, Kawaji H, Iba T, et al. CD157 marks tissue-resident endothelial stem cells with homeostatic and regenerative properties. Cell Stem Cell. 2018;22(3):384-397.e6.","journal-title":"Cell Stem Cell"},{"issue":"1\u20132","key":"10106_CR179","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yexcr.2018.10.003","volume":"373","author":"M Waldman","year":"2018","unstructured":"Waldman M, Nudelman V, Shainberg A, Abraham NG, Kornwoski R, Aravot D, et al. PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1\u03b1 axis. Exp Cell Res. 2018;373(1\u20132):112\u20138.","journal-title":"Exp Cell Res"},{"issue":"1","key":"10106_CR180","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2119\/molmed.2014.00156","volume":"20","author":"TD Walko","year":"2015","unstructured":"Walko TD, Di Caro V, Piganelli J, Billiar TR, Clark RSB, Aneja RK. Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion. Mol Med. 2015;20(1):612\u201324.","journal-title":"Mol Med"},{"issue":"10","key":"10106_CR181","doi-asserted-by":"publisher","first-page":"15754","DOI":"10.3390\/molecules191015754","volume":"19","author":"S Wang","year":"2014","unstructured":"Wang S, Zhu W, Wang X, Li J, Zhang K, Zhang L, et al. Design, synthesis and SAR studies of NAD analogues as potent inhibitors towards CD38 NADase. Molecules. 2014;19(10):15754\u201367.","journal-title":"Molecules"},{"issue":"1","key":"10106_CR182","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12944-017-0464-z","volume":"16","author":"LF Wang","year":"2017","unstructured":"Wang LF, Wang XN, Huang CC, Hu L, Xiao YF, Guan XH, et al. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1\/AMPK\u03b1\/SREBP1 signaling pathway. Lipids Health Dis. 2017;16(1):82.","journal-title":"Lipids Health Dis"},{"key":"10106_CR183","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.redox.2018.04.006","volume":"17","author":"S Wang","year":"2018","unstructured":"Wang S, Wan T, Ye M, Qiu Y, Pei L, Jiang R, et al. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1\/PGC-1\u03b1\/mitochondrial biosynthesis pathway. Redox Biol. 2018;17:89\u201398.","journal-title":"Redox Biol"},{"issue":"9","key":"10106_CR184","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/ptr.6417","volume":"33","author":"S Wang","year":"2019","unstructured":"Wang S, Yang FJ, Shang LC, Zhang YH, Zhou Y, Shi XL. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1\/PI3K\/AKT signaling pathway and facilitating mitochondrial homeostasis. Phytother Res. 2019;33(9):2347\u201359.","journal-title":"Phytother Res"},{"key":"10106_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114260","volume":"236","author":"L Wang","year":"2022","unstructured":"Wang L, Liu M, Zu Y, Yao H, Wu C, Zhang R, et al. Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy. Eur J Med Chem. 2022;236:114260.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10106_CR186","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41386-022-01373-7","volume":"47","author":"C Wang","year":"2022","unstructured":"Wang C, Zhang Y, Zhao D, Huo Y, Xie J, Zhang X, et al. Phenazopyridine promotes RPS23RG1\/Rps23rg1 transcription and ameliorates alzheimer-associated phenotypes in mice. Neuropsychopharmacology. 2022;47(12):2042\u201350.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10106_CR187","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41598-017-00851-z","volume":"7","author":"CC Wei","year":"2017","unstructured":"Wei CC, Kong YY, Li GQ, Guan YF, Wang P, Miao CY. Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2\/HO-1 signaling pathway. Sci Rep. 2017;7(1):717.","journal-title":"Sci Rep"},{"key":"10106_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.117595","volume":"99","author":"F Wen","year":"2024","unstructured":"Wen F, Gui G, Wang X, Ye L, Qin A, Zhou C, et al. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): updated progress and perspectives. Bioorg Med Chem. 2024;99:117595.","journal-title":"Bioorg Med Chem"},{"key":"10106_CR189","doi-asserted-by":"crossref","unstructured":"Wen et al Y W, J L, C J, F T. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol. 2021;18(1):45\u201356.","DOI":"10.1038\/s41423-020-00558-8"},{"issue":"10","key":"10106_CR190","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1042\/BCJ20170046","volume":"474","author":"R Willows","year":"2017","unstructured":"Willows R, Navaratnam N, Lima A, Read J, Carling D. Effect of different \u03b3-subunit isoforms on the regulation of AMPK. Biochem J. 2017;474(10):1741\u201354.","journal-title":"Biochem J"},{"issue":"1","key":"10106_CR191","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7(1):402.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10106_CR192","volume":"33","author":"L Xia","year":"2023","unstructured":"Xia L, Ma W, Afrashteh A, Sajadi MA, Fakheri H, Valilo M. The nuclear factor erythroid 2-related factor 2\/p53 axis in breast cancer. Biochem Med (Zagreb). 2023;33(3):030504.","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"10106_CR193","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.14336\/AD.2023.0203","volume":"14","author":"H Xiao","year":"2023","unstructured":"Xiao H, Xie Y, Xi K, Xie J, Liu M, Zhang Y, et al. Targeting mitochondrial sirtuins in age-related neurodegenerative diseases and fibrosis. Aging Dis. 2023;14(5):1583\u2013605.","journal-title":"Aging Dis"},{"issue":"15","key":"10106_CR194","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.7150\/ijbs.65588","volume":"17","author":"L Xie","year":"2021","unstructured":"Xie L, Wen K, Li Q, Huang CC, Zhao JL, Zhao QH, et al. CD38 deficiency protects mice from high fat diet-induced nonalcoholic fatty liver disease through activating NAD+\/sirtuins signaling pathways-mediated inhibition of lipid accumulation and oxidative stress in hepatocytes. Int J Biol Sci. 2021;17(15):4305\u201315.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"10106_CR195","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212523","volume":"14","author":"X Xiong","year":"2019","unstructured":"Xiong X, Yu J, Fan R, Zhang C, Xu L, Sun X, et al. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice. PLoS ONE. 2019;14(2):e0212523.","journal-title":"PLoS ONE"},{"issue":"1","key":"10106_CR196","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00432-022-04447-7","volume":"149","author":"J Xu","year":"2023","unstructured":"Xu J, Zhu K, Wang Y, Chen J. The dual role and mutual dependence of heme\/HO-1\/Bach1 axis in the carcinogenic and anti-carcinogenic intersection. J Cancer Res Clin Oncol. 2023;149(1):483\u2013501.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10106_CR197","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/molecules29040798","volume":"29","author":"C Xu","year":"2024","unstructured":"Xu C, Dai J, Ai H, Du W, Ji H. \u0392-nicotinamide mononucleotide promotes cell proliferation and hair growth by reducing oxidative stress. Molecules. 2024;29(4):798.","journal-title":"Molecules"},{"issue":"4","key":"10106_CR198","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s42255-020-0194-9","volume":"2","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhang N, Zhang G, Sauve AA. NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase. Nat Metab. 2020;2(4):364\u201379.","journal-title":"Nat Metab"},{"key":"10106_CR199","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang H, Wang H, Andersson U.\u00a0Targeting inflammation driven by HMGB1. Front Immunol. 2020;11:484.","journal-title":"Front Immunol"},{"issue":"10","key":"10106_CR200","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/biomedicines9101440","volume":"9","author":"H Yang","year":"2021","unstructured":"Yang H, Mayneris-Perxachs J, Boqu\u00e9 N, Del Bas JM, Arola L, Yuan M, et al. Combined metabolic activators decrease liver steatosis by activating mitochondrial metabolism in hamsters fed with a high-fat diet. Biomedicines. 2021;9(10):1440.","journal-title":"Biomedicines"},{"key":"10106_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2021.129727","volume":"273","author":"D Yang","year":"2021","unstructured":"Yang D, Zhang X, Yue L, Hu H, Wei X, Guo Q, et al. Thiamethoxam induces nonalcoholic fatty liver disease in mice via methionine metabolism disturb via nicotinamide N-methyltransferase overexpression. Chemosphere. 2021;273:129727.","journal-title":"Chemosphere"},{"issue":"1","key":"10106_CR202","first-page":"148","volume":"26","author":"D Yang","year":"2022","unstructured":"Yang D, Xie J, Liang XC, Cui YZ, Wu QL. The synergistic effect of palmitic acid and glucose on inducing endoplasmic reticulum stress-associated apoptosis in rat schwann cells. Eur Rev Med Pharmacol Sci. 2022;26(1):148\u201357.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10106_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114987","volume":"164","author":"N Yang","year":"2023","unstructured":"Yang N, Sun R, Zhang X, Wang J, Wang L, Zhu H, et al. Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT\/NAD+\/SIRT1 axis. Biomed Pharmacother. 2023;164:114987.","journal-title":"Biomed Pharmacother"},{"issue":"36","key":"10106_CR204","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.3748\/wjg.v25.i36.5434","volume":"25","author":"TJ Ye","year":"2019","unstructured":"Ye TJ, Lu YL, Yan XF, Hu XD, Wang XL. High mobility group box-1 release from H2O2-injured hepatocytes due to sirt1 functional inhibition. World J Gastroenterol. 2019;25(36):5434\u201350.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10106_CR205","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jn\/nxz303","volume":"150","author":"L Ye","year":"2020","unstructured":"Ye L, Cao Z, Lai X, Shi Y, Zhou N. Niacin ameliorates hepatic steatosis by inhibiting de novo lipogenesis via a GPR109A-mediated PKC-ERK1\/2-AMPK signaling pathway in C57BL\/6 mice fed a high-fat diet. J Nutr. 2020;150(4):672\u201384.","journal-title":"J Nutr"},{"issue":"4","key":"10106_CR206","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino J, Mills KF, Yoon MJ, Imai IS. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528\u201336.","journal-title":"Cell Metab"},{"issue":"6547","key":"10106_CR207","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224\u20139.","journal-title":"Science"},{"key":"10106_CR208","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"10","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2024;10:1999-2010.e8.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10106_CR209","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025(Suppl):S32\u201350.","DOI":"10.3350\/cmh.2024.0431"},{"issue":"5","key":"10106_CR210","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11596-016-1645-0","volume":"36","author":"F Yu","year":"2016","unstructured":"Yu F, Zeng H, Lei M, Xiao DM, Li W, Yuan H, et al. Effects of SIRT1 gene knock-out via activation of SREBP2 protein-mediated PI3K\/AKT signaling on osteoarthritis in mice. J Huazhong Univ Sci Technolog Med Sci. 2016;36(5):683\u201390.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"10106_CR211","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/fsn3.2007","volume":"9","author":"X Yu","year":"2021","unstructured":"Yu X, Xue M, Liu Y, Zhou Z, Jiang Y, Sun T, et al. Effect of nicotinamide riboside on lipid metabolism and gut microflora-bile acid axis in alcohol-exposed mice. Food Sci Nutr. 2021;9(1):429\u201340.","journal-title":"Food Sci Nutr"},{"key":"10106_CR212","doi-asserted-by":"publisher","first-page":"1147710","DOI":"10.3389\/fimmu.2023.1147710","volume":"14","author":"W Yu","year":"2023","unstructured":"Yu W, Wang S, Wang Y, Chen H, Nie H, Liu L, et al. MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis. Front Immunol. 2023;14:1147710.","journal-title":"Front Immunol"},{"issue":"43","key":"10106_CR213","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1038\/s41388-023-02831-2","volume":"42","author":"A Yu","year":"2023","unstructured":"Yu A, Yu P, Zhu Y, Zhu R, Sun R, Ye D, et al. Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development. Oncogene. 2023;42(43):3182\u201393.","journal-title":"Oncogene"},{"issue":"4","key":"10106_CR214","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001826R","volume":"35","author":"R Zapata-P\u00e9rez","year":"2021","unstructured":"Zapata-P\u00e9rez R, Tammaro A, Schomakers BV, Scantlebery AML, Denis S, Elfrink HL, et al. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. FASEB J. 2021;35(4):e21456.","journal-title":"FASEB J"},{"issue":"2","key":"10106_CR215","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1096\/fj.201700602R","volume":"32","author":"B Zhang","year":"2018","unstructured":"Zhang B, Xu D, She L, Wang Z, Yang N, Sun R, et al. Silybin inhibits NLRP3 inflammasome assembly through the NAD+\/SIRT2 pathway in mice with nonalcoholic fatty liver disease. FASEB J. 2018;32(2):757\u201367.","journal-title":"FASEB J"},{"issue":"1","key":"10106_CR216","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41418-019-0356-z","volume":"27","author":"T Zhang","year":"2020","unstructured":"Zhang T, Liu J, Shen S, Tong Q, Ma X, Lin L. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Cell Death Differ. 2020;27(1):329\u201344.","journal-title":"Cell Death Differ"},{"issue":"8","key":"10106_CR217","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1007\/s10571-023-01427-4","volume":"43","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu B, Lal K, Liu H, Tran M, Zhou M, et al. Antioxidant system and endoplasmic reticulum stress in cataracts. Cell Mol Neurobiol. 2023;43(8):4041\u201358.","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10106_CR218","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/iub.2707","volume":"75","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhu W, Wang M, Xi P, Wang H, Tian D. Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet. IUBMB Life. 2023;75(6):548\u201362.","journal-title":"IUBMB Life"},{"issue":"1","key":"10106_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02250-8","volume":"18","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, et al. NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway. J Neuroinflammation. 2021;18(1):207.","journal-title":"J Neuroinflammation"},{"key":"10106_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108712","volume":"108","author":"X Zhao","year":"2022","unstructured":"Zhao X, Xue X, Wang C, Wang J, Peng C, Li Y. Emerging roles of sirtuins in alleviating alcoholic liver disease: a comprehensive review. Int Immunopharmacol. 2022;108:108712.","journal-title":"Int Immunopharmacol"},{"issue":"Pt 1","key":"10106_CR221","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.freeradbiomed.2022.10.267","volume":"193","author":"X Zhao","year":"2022","unstructured":"Zhao X, Zhang M, Wang J, Ji K, Wang Y, Sun X, et al. NMN ameliorated radiation induced damage in NRF2-deficient cell and mice via regulating SIRT6 and SIRT7. Free Radic Biol Med. 2022;193(Pt 1):342\u201353.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10106_CR222","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12967-023-04367-1","volume":"21","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang S, Wu J, Wang Y. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. J Transl Med. 2023;21(1):510.","journal-title":"J Transl Med"},{"issue":"6","key":"10106_CR223","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jhep.2010.05.034","volume":"53","author":"M Zhou","year":"2010","unstructured":"Zhou M, Xu A, Lam KSL, Tam PKH, Che CM, Chan L, et al. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. J Hepatol. 2010;53(6):1108\u201316.","journal-title":"J Hepatol"},{"issue":"15","key":"10106_CR224","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1111\/bph.13513","volume":"173","author":"CC Zhou","year":"2016","unstructured":"Zhou CC, Yang X, Hua X, Liu J, Fan MB, Li GQ, et al. Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. Br J Pharmacol. 2016;173(15):2352\u201368.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10106_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166249","volume":"1867","author":"C Zhu","year":"2021","unstructured":"Zhu C, Huang M, Kim HG, Chowdhury K, Gao J, Liu S, et al. SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1. Biochimica Et Biophysica Acta (BBA). 2021;1867(12):166249.","journal-title":"Biochimica Et Biophysica Acta (BBA)"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10106-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T03:02:50Z","timestamp":1764126170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10106-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":225,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10106"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10106-7","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"156"}}